COSMOS Pharmaceutical Operating Income

COSMOS Pharmaceutical (CSMYF) currently reports a operating income of $42B as of May 2026. That compares with $40B in the prior-year period — up 4.8% year over year. Use the charts on this page to explore COSMOS Pharmaceutical's operating income history and peer comparisons.

COSMOS Pharmaceutical's operating income increased from $40B to $42B — a 4.8% year-over-year increase (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

COSMOS Pharmaceutical reported $42B in operating income as of May 2026. That compares with $40B in the prior-year period — up 4.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $42B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for COSMOS Pharmaceutical, and consider following CSMYF for alerts when major investors trade the stock.